Your browser doesn't support javascript.
loading
First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%: Real-World Study Including Older Patients in Japan.
Goto, Yasushi; Tamura, Atsuhisa; Matsumoto, Hirotaka; Isobe, Kazutoshi; Ozaki, Tomohiro; Santorelli, Melissa L; Taniguchi, Kazuko; Kamitani, Tetsu; Irisawa, Masato; Kanda, Kingo; Abe, Machiko; Burke, Thomas; Nokihara, Hiroshi.
Affiliation
  • Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Tamura A; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
  • Matsumoto H; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.
  • Isobe K; Department of Respiratory Medicine, Toho University School of Medicine, Tokyo, Japan.
  • Ozaki T; Division of Medical Oncology, Kishiwada City Hospital, Osaka, Japan.
  • Santorelli ML; Center for Observational & Real World Evidence (CORE), Merck & Co., Inc., Rahway, New Jersey.
  • Taniguchi K; MSD K.K., Tokyo, Japan.
  • Kamitani T; MSD K.K., Tokyo, Japan.
  • Irisawa M; MSD K.K., Tokyo, Japan.
  • Kanda K; MSD K.K., Tokyo, Japan.
  • Abe M; MSD K.K., Tokyo, Japan.
  • Burke T; Center for Observational & Real World Evidence (CORE), Merck & Co., Inc., Rahway, New Jersey.
  • Nokihara H; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
JTO Clin Res Rep ; 3(9): 100397, 2022 Sep.
Article in En | MEDLINE | ID: mdl-36065450
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: JTO Clin Res Rep Year: 2022 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: JTO Clin Res Rep Year: 2022 Document type: Article Affiliation country: Japan